Blocking a protein early may help chemo keep working in glioblastoma
Original title: Early WEE1 inhibition prevents senescence-like epigenetic reprogramming of pioneer TMZ-resistant cells and synergizes with temozolomide in MYC-high glioblastoma.
How far along is this research?
- Lab cells
- Animals
- Review
- Tested in people
This was done in animals, not people. Most findings at this stage never become treatments.
This was only done in lab cells and in mice.
The short version
In lab cells and in mice, blocking a protein called WEE1 early helped the chemo drug temozolomide: A chemotherapy taken as a capsule, used for some brain tumors. Your team checks your blood counts while you are on it. See the glossary work better.
What was studied. Scientists studied glioblastoma: A glioma that is given grade 4. Grade 4 is the highest grade there is. The tumor grows fast. Treatment usually starts soon after it is found. It often means surgery, and then radiation and chemotherapy. See the glossary cells taken from patients with high activity of a gene called MYC. They tested TSL2304, a new drug that blocks a protein called WEE1, in these cells and in mice.
What they found. Some tumor cells lived through the first round of temozolomide: A chemotherapy taken as a capsule, used for some brain tumors. Your team checks your blood counts while you are on it. See the glossary. These survivor cells changed the way their genes were switched on and off. That shift made them harder to kill with the drug. Blocking WEE1 early stopped that shift and helped the chemo work. Mice given this early treatment lived longer.
What this means, and what it doesn't
What it could mean: This offers one idea about why chemo stops working for some people with glioblastoma: A glioma that is given grade 4. Grade 4 is the highest grade there is. The tumor grows fast. Treatment usually starts soon after it is found. It often means surgery, and then radiation and chemotherapy. See the glossary. Timing may matter a lot. If this holds up, a WEE1 blocker given early with chemo might slow resistance. That is a question for future studies, not a treatment choice today.
What it doesn't mean: This is not a cure, and it is not care you can ask for now. The work was done in cells in a dish and in mice. No people were treated with TSL2304 in this study. Many results in mice do not work the same way in people. Nothing here changes your treatment today.
Source: PubMed, October 23, 2026 · Read the original
This plain-language summary was written by AI and published automatically after passing our automatic safety checks. How we write.